A method and apparatus for quantifying the structure and dynamics of biomolecules by graphene-induced energy transfer

Through graphene-induced energy transfer (GIET) method and non-covalent surface-coated amphiphilic molecules, the problem of structure and kinetic determination of large-size protein complexes is solved, and high-precision analysis and automatic screening are achieved, maintaining the The integrity and function of biomolecules.

CN113686824BActive Publication Date: 2024-11-19游长江 +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202110542583.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-05-19
Filing Date
2021-05-18
Publication Date
2024-11-19
Estimated Expiration
2041-05-18

AI Technical Summary

Technical Problem

It is difficult to determine the structure and kinetics of large-sized protein complexes with high accuracy in the prior art, and the non-covalent biological functionalization method of graphene needs to avoid deterioration of electronic properties while maintaining protein structural integrity.

Method used

Using graphene-induced energy transfer (GIET) method, the site-specific fixation of the biomolecules is achieved by transferring the graphene layer to the support layer and using non-covalent surface-coated amphiphilic molecules for biofunctionalization. and fluorescence quenching assays to quantitatively analyze the size and kinetics of biomolecules.

Benefits of technology

High-precision structural and kinetic analysis of nucleotides, proteins and protein complexes is achieved, the integrity and function of biomolecules are maintained, sample consumption and analysis time are reduced, and it is suitable for automatic large-scale screening of candidate drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113686824B_ABST
    Figure CN113686824B_ABST
Patent Text Reader

Abstract

The present invention relates to the determination of the structure and activity of biomolecules, and belongs to the field of biosensor applications. Specifically, the present invention obtains a biofunctionalized graphene layer by developing an amphiphilic coating, thereby preparing a sensor that is sensitive to biomolecules, and can perform sub-nanometer precision analysis of protein structure and sensitive detection of nucleic acid molecule hybridization. The biofunctionalized graphene layer obtained by the amphiphilic coating, the analysis method for the structure and activity of biomolecules, and the obtained sensor device have wide applications in scientific research, medical diagnosis, and drug screening.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention generally relates to the determination of the structure and activity of biomolecules. More specifically, the present invention relates to methods of making devices having a support layer and a biofunctionalized graphene layer on the support layer, and the use of such devices for determining the structure and structural dynamics of biomolecules, especially nucleotide hybridization, proteins and protein complexes. The present invention also relates to novel compounds for graphene biofunctionalization, especially novel amphiphilic molecules for non-covalent surface coating of graphene layers, and their use in the manufacturing methods and devices of the present invention. Background Art

[0002] Knowledge about the structure of proteins and protein complexes is crucial to understand their functions, especially in the context of pharmaceutical applications. Fluorescence methods based on Foerster (fluorescence) resonance energy transfer (FRET) have been widely used for the exploration of protein structures. Without the need for sophisticated instrumentation, FRET and its derivative luminescence (or lanthanide-based) resonance energy transfer (LRET) methods report on the structural dynamics of proteins in the complex biological environment of living cells.

[0003] The rate of FRET varies with the intermolecular distance r and the Foerster radius R0 (r / R0). -6 Since R0 is usually a few nanometers, the effective range of FRET is within 10nm. However, many proteins have a hydrodynamic radius that extends beyond this distance. It is also quite common for protein complexes composed of multiple subunits to have large sizes of tens of nanometers. Therefore, there is an urgent need in the art to develop methods with spatial precision similar to FRET but with extended sensitivity distances.

[0004] Fluorescence quenching of fluorescent chromophores near graphene has been widely used in biosensing. When close to but not in contact with graphene, the excited fluorescent chromophores undergo long-range radiationless electromagnetic coupling with graphene plasmons. This phenomenon is similar to metal-induced energy transfer (MIET) (Chizhik et al., 2014, Nature Photonics, Vol. 8, p. 124), and is hereinafter referred to as graphene-induced energy transfer (GIET).

[0005] The atomic thickness of graphene ensures high optical transparency and extremely high plasmon confinement. Theoretical calculations have predicted that the energy transfer rate of GIET depends on the perpendicular distance d to graphene as -4(Swathi et al., 2009, TheJournal of Chemical Physics, Vol. 130, No. 8, pp. 086-101). The sensitive region of GIET is predicted to be up to 30nm, which is very attractive for structural biology. However, for the application of GIET in protein structure analysis, the surface biofunctionalization of graphene is a key prerequisite. The deterioration of graphene electronic properties must be avoided, while the structural integrity of proteins and protein complexes should be maintained. Commonly used graphene oxidation introduces the modification of carbon bonds. These modifications can affect graphene plasmons (Dreyer et al., 2010, Chemical Society Reviews, Vol. 39, No. 1, p. 228), thereby changing the distance correlation mode of GIET. For these reasons, the non-covalent biofunctionalization of graphene becomes a basic requirement. In addition, the site-specific fixation of proteins on non-covalently modified graphene is conducive to ensuring complete protein functionality and controlled protein orientation.

[0006] There is a need in the art for novel methods for quantitatively detecting the structure and dynamics of a large number of biomolecules using GIET and for developing novel compounds for non-covalent biofunctionalization of graphene. Such GIET-based methods and products can reduce sample consumption and save analysis time, while enabling automated large-scale screening of candidate drugs by integrating GIET devices with microfluidic systems, sampling systems, etc. The present invention addresses the need in the art through the subject matter disclosed and claimed herein. Summary of the invention

[0007] The present invention provides a novel method for manufacturing a device having a support layer and a biofunctionalized graphene layer on the support layer, and the use of such a device for hybridization, determination of the structure and dynamics of biomolecules, especially nucleotides, proteins and protein complexes. In addition, the present invention provides novel compounds for graphene biofunctionalization, especially novel amphiphilic molecules for non-covalent surface coating of graphene layers, and their use in the manufacturing method and device of the present invention.

[0008] Surprisingly, it has been found that the distance dependence of graphene-induced energy transfer (graphene induced energy transfer, GIET) can be calibrated, thereby being used for the high-precision quantitative analysis of the size and dynamics of structurally defined biomolecules, which include, for example, nucleotides, proteins, protein complexes, proteins with intrinsic disordered domains, or protein complexes with a size of up to 50nm. The invention provides biofunctionalization of graphene layers for site-specific fixation of biomolecules, thereby determining structure or conformational changes. Surprisingly, it has been found that the non-covalent biofunctionalization of graphene of the present invention, used in the method based on GIET, can keep the structural integrity of biomolecules and can control their orientation. Therefore, the function of biomolecules in terms of interacting with other molecules is retained.

[0009] The GIET-based method of the present invention is characterized by comprising three main steps:

[0010] (i) transferring a (commercially available) graphene (mono)layer onto a support layer (e.g. a glass substrate);

[0011] (ii) biofunctionalizing the surface of the graphene layer for site-specific immobilization of biomolecules; and

[0012] (iii) Fluorescence quenching is measured to obtain the vertical distance between the fluorescent chromophore and graphene.

[0013] In one aspect, the present invention provides a method for manufacturing a device including a biofunctionalized graphene layer on a support layer. In a second aspect, the present invention provides a novel amphiphilic molecule for non-covalent surface coating of a graphene layer. The hydrophobic end can utilize van der Waals interactions through lipid analogs, or utilize π-π interactions through pyrene or dibenzocyclooctyne (DBCO). Affinity capture moieties, such as tris-nitrilotriacetic acid (tris-NTA), can be introduced into the other end for site-specific, reversible fixation of biomolecules. The ends can be connected by polyethylene glycol (PEG). In a third aspect, the present invention provides a device manufactured by the method disclosed herein. In a fourth aspect, the present invention provides the use of the manufacturing device disclosed herein for verifying distance-dependent GIET by fluorescence intensity and / or fluorescence lifetime. The transparency of graphene allows lifetime determination to be completed very quickly. DNA can be used as a geometrically defined nanoruler. In a fifth aspect of the invention, the means and methods disclosed herein for biofunctionalized graphene on a support layer can be used as a device, in particular, for DNA hybridization assays, including clinical PCR (polymerase chain reaction) tests of target genomic sequences. In a sixth aspect, the invention provides methods for using the manufacturing devices disclosed herein to determine size, structure, or dynamics, including conformational changes of biomolecules, in particular nucleotides, structurally defined proteins, protein complexes, proteins with intrinsic disordered domains, or protein complexes with a size of up to 50 nm. In a seventh aspect of the invention, the methods, devices, and compositions provided herein can be used in analytical or diagnostic applications.

[0014] The present invention provides, in particular:

[0015] [1] A method for manufacturing a device having a support layer and a biofunctionalized graphene layer on the support layer, characterized in that the method comprises the following steps:

[0016] (a) transferring the graphene layer to a support layer to form a support layer having the graphene layer thereon;

[0017] (b) applying an amphiphilic coating to the graphene layer of step (a) to form a non-covalent surface coating on the graphene layer; and

[0018] (c) Obtaining a device having a support layer and a biofunctionalized graphene layer on the support layer.

[0019] [2] The method according to [1], wherein the amphiphilic coating comprises amphiphilic molecules having a hydrophobic group and a hydrophilic group, and the hydrophobic group and the hydrophilic group may be connected via a linking group or not.

[0020] [3] The method according to [1] or [2], wherein:

[0021] (i) the hydrophilic group comprises an affinity capture moiety, and / or

[0022] (ii) the hydrophobic group comprises any one of the following: a polycyclic aromatic hydrocarbon derivative, preferably pyrene; a cycloalkyne, preferably a cyclooctyne derivative, more preferably a benzo-fused cyclooctyne derivative; a surface adhesion protein, preferably bovine serum albumin; and / or an aliphatic amine, preferably a fatty amine derivative, more preferably an octadecylamine derivative.

[0023] [4] The method according to [3], wherein the affinity capture portion is a target analyte capture portion, and wherein the target analyte is a biological molecule, which includes any one of a peptide or protein, an aptamer, a nucleic acid, a lipid and a carbohydrate, wherein the target analyte is preferably a proteinogenic molecule or a nucleic acid molecule, more preferably a protein, DNA or RNA.

[0024] [5] The method according to [4], wherein the affinity capture part is

[0025] (a) a protein-capturing ligand, wherein the protein-capturing ligand is preferably a haloalkane derivative, more preferably a chloroalkane derivative; or

[0026] (b) a nucleic acid capture ligand, wherein the nucleic acid capture ligand is preferably a complementary nucleic acid sequence, avidin or streptavidin or a binding protein; or

[0027] (c) a chelating agent, preferably a carboxylic acid-based chelating agent, more preferably a diacetic acid- or triacetic acid-based chelating agent, wherein the chelating agent is preferably a sequestering agent.

[0028] [6] The method according to any one of [2] to [5], wherein the hydrophobic group and the hydrophilic group are connected via a linking group, wherein the linking group is preferably a polymer, wherein the linking group is more preferably poly(ethylene glycol) (PEG).

[0029] [7] The method according to [1] or [2], wherein the amphiphilic coating comprises amphiphilic molecules without affinity capture moieties.

[0030] [8] The method according to any one of [1] to [7], further comprising the step of fixing a target analyte to the non-covalently modified surface of the graphene layer in step (c).

[0031] [9] The method according to [8], wherein the target analyte is immobilized to the non-covalent surface of the graphene layer by targeting or linking to a functional portion of the one or more amphiphilic molecules, wherein the functional portion is preferably targeted or linked to a hydrophilic group of the one or more amphiphilic molecules.

[0032]

[10] A method according to any one of [1] to [9], wherein the support layer comprises any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, wherein the support layer preferably comprises a silica-based substrate, more preferably comprises silica glass.

[0033]

[11] A graphene induced energy transfer (GIET) device comprising a support layer and a [bio]functionalized graphene layer on the support layer, the device being obtainable by the method described in any one of [1] to

[10] .

[0034]

[12] A method for determining the structure and / or dynamics of a target analyte, the method comprising immobilizing the target analyte to a device according to claim

[11] and determining the distance-dependent GIET efficiency, preferably by fluorescence quenching.

[0035]

[13] The method according to

[12] is used to determine the axial size and / or axial conformational change of the target analyte.

[0036]

[14] The GIET device according to

[11] or the method according to

[12] or

[13] , wherein the detectable GIET area is about 1 nm to 50 nm, preferably 3 nm to 40 nm, and more preferably 5 nm to 30 nm.

[0037]

[15] Use of the device according to

[11] in screening, analysis and / or diagnostic applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 : Calibration of distance-dependent GIET. (A) Schematic diagram of DNA nanoruler. The probe strands are conjugated to fluorescein (shown as asterisks) at the 3' or 5' end, respectively. (B) Plot of unquenched fluorescence as a function of the perpendicular distance d from the fluorescent chromophore to the graphene surface, measured by intensity ratio (squares, left axis) and lifetime ratio (dots, right axis). Values ​​are mean ± SD from 3 independent measurements. The curves represent theoretical predictions. The inset is a scheme for calculating d. The gray areas on graphene represent non-covalent coatings on graphene.

[0039] Figure 2 : Binding of hexahistidine-tagged anti-GFP nanobody to GFP detected by surface-sensitive RIfs-TIRFs. (A) Mass signals detected by reflectance interference spectroscopy (RIfs) for lipid coating (I), His-tagged NB immobilization (III), and unlabeled mEGFP binding (IV), marked by gray bars. (B) Synchronous time-lapse fluorescence intensity tracing. Dashed line: silica sensor. Solid line: graphene-coated silica sensor.

[0040] Figure 3 : Axial distance between NB::GFP complex and GFP measured by GIET. (A) I distance between NB::GFP complex and GFP measured by surface sensitive RIfs-TIRFs. GIET / I0 ratio. (B) Cartoon showing quantified axial distance.

[0041] Figure 4 : Quantification of conformational changes of DNA by GIET. (A) Schematic diagram of the conformational changes of a 35-mer ssDNA anchor on graphene. (B) Time-correlated single photon counts of probe strands hybridized to a 35-mer anchor DNA strand under different conditions. Gray curve: no 15-mer blocker on graphene. Black curve 2: presence of 15-mer blocker on graphene. Black curve 1: presence of 15-mer blocker on glass.

[0042] Figure 5 : Molecular structures of TrisNTA-PEG-DBCO and trisNTA-PEG-pyrene.

[0043] Figure 6 :Label-free solid phase detection of TrisNTA-PEG-pyrene / PEG-pyrene coating (I), treatment and Ni 2+ Loading (II), and immobilization of hexahistidine-GFP (III). (IV) is an imidazole washing step.

[0044] Figure 7 : Label-free solid phase detection of GFP binding to HaloTag-DARPin::BSA-HTL functionalized graphene (black line). The grey line represents the negative control, where GFP binding to BSA functionalized graphene is negligible. Specific implementation plan

[0045] The present invention provides a method for manufacturing a device having a support layer and a biofunctionalized graphene layer on the support layer, characterized in that the method comprises the following steps:

[0046] (a) transferring the graphene layer to a support layer to form a support layer having the graphene layer thereon;

[0047] (b) applying an amphiphilic coating to the graphene layer of step (a) to form a non-covalent surface coating on the graphene layer; and

[0048] (c) Obtaining a device having a support layer and a biofunctionalized graphene layer on the support layer.

[0049] As used herein, the term "device" means any instrument suitable for measuring a sample by the method, and can be used interchangeably with the term "chip". Typical devices of the present invention are manufactured according to the methods described herein. According to the present invention, the term "device" refers to an object for quantitatively measuring and / or detecting the structure and dynamics of biomolecules. In the present invention, the device includes a biofunctionalized graphene layer on a support layer. The device may include a solid surface on a support layer. The term "solid surface" refers to a material with a rigid or semi-rigid surface. As used herein, the device is designed to contact a sample with one or more biomolecules, which may or may not have the ability to bind to the device (support layer or solid surface). The solid surface can be selected according to its intrinsic ability to attract and fix biomolecules. Alternatively, the solid surface can retain a connecting molecule with the ability to attract and fix biomolecules. As described herein, the biofunctionalized graphene layer can be on the solid surface of the support layer.

[0050] As used herein, the term "graphene" includes the common meaning of the term and describes pure carbon or near-pure carbon in a single-atom-thick layer, in which carbon atoms are densely packed in a regular sp2-bonded atomic-level hexagonal pattern. As used herein, a "graphene layer" includes not only a graphene monolayer, but also a plurality of graphene layers. For convenience, a single "graphene layer" is used throughout the disclosure, which may refer to a single layer similar to a graphene monolayer or a plurality of graphene layers. In various embodiments, the graphene layer may include a plurality of graphene layers, including two, three, four, five, etc. graphene layers. In a preferred embodiment, the graphene layer is a graphene monolayer. In addition, as used herein, a "graphene layer" includes not only a continuous graphene layer, but also a discontinuous graphene layer. In a preferred embodiment, the graphene layer is continuous. As used herein, the term "continuous" means that the coating of the graphene layer has an uninterrupted extension along the surface. Other ways of describing continuity include, but are not limited to, "constantly" or "repeatedly in rapid succession". Therefore, as used herein, the term "continuous" refers to a layer that covers the entire surface without a gap or exposed point that allows the material below the layer (i.e., the supporting layer) to leak out. As used herein, the term "continuous" is intended to include graphene layers with unintentional, intermittent, isolated interruptions or gaps from discontinuous deposits (e.g., from manufacturing defects). These gaps or exposed points on the surface may be less than about 1% of the total surface area. And in the embodiment in which the graphene layer is discontinuous, there are no special requirements for the spatial arrangement of the discontinuous graphene layer. They may be arranged on the supporting layer periodically or non-periodically. In all the above-mentioned embodiments, there is no preferred shape of the graphene layer, and these preferred shapes include but are not limited to squares, stripes, spheres, triangles, ellipses or other irregular shapes. In various embodiments, the length of the graphene layer is at least 100nm. In a preferred embodiment, the length of the graphene layer is greater than 100nm. Other preferred length scales of the graphene layers are at least 200 nm, 300 nm, 400 nm, 500 nm, 600 nm, 700 nm, 800 nm, 1 μm. Even more preferably, greater than 1 μm, 10 μm, 100 μm and 1 mm, 5 mm. In various embodiments, the thickness of the graphene monolayer used according to the present invention is about 0.34 nm. In other embodiments, depending on the number of graphene layers, the thickness is at most 0.5 nm, preferably at most a few nanometers.

[0051] As used herein, the term "support layer" refers to a layer that provides mechanical support for a biofunctionalized graphene layer. As used herein, a support layer is a material with a rigid or semi-rigid surface. In various embodiments, such as in the case of a support layer on which a biofunctionalized graphene layer is formed, at least one surface of the support layer will be substantially flat. In the case of a compound or material library, it may be desirable to physically separate the synthesis region in a support layer for different materials, for example, a recessed portion, a hole, a raised area, an etched groove, etc. In some embodiments, the support layer for a compound or material library itself will contain all or part of the holes, raised areas, etched grooves, etc. that form the synthesis region. In one embodiment of the present invention, the support layer provides a suitable solid foundation to which the biofunctionalized graphene layer is transferred. In a preferred embodiment, the support layer of the present invention is a support layer based on silicon dioxide. As used herein, "silicon dioxide" is a material having silicon (Si) and oxygen (O) atoms, and possible additional substituents, and possible additional substituents such as but not limited to other elements, such as H, C, B, P or halogen atoms; alkyl; or aryl. In some cases, the material may further include silicon-carbon bonds, the total number of Si-C bonds relative to the total number of Si atoms ranging from about 20 mol% to about 80 mol%, or from about 40 mol% to about 60 mol%. The silica support layer preferably includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, the support layer preferably includes a silica-based substrate, more preferably includes silica glass, the silica glass can be selected from 1×1 cm 2 Silicon dioxide coated sensors or glass microscope coverslips.

[0052] In a preferred embodiment, the silicon dioxide used herein is in the form of a silicon dioxide coated sensor. As used herein, the term "sensor" refers to any type of functional component or functional component arrangement configured to convert energy from one form to another and / or configured to convert an input signal. In a further preferred embodiment, the silicon dioxide coated sensor is used for reflection interference spectroscopy and total internal reflection fluorescence spectroscopy detection (RIfs-TIRFs). In another preferred embodiment, the silicon dioxide substrate used herein is a glass microscope cover glass. As used herein, "cover glass" refers to a thin strip of glass for supporting a biological sample to be observed under a microscope. The cover glass should have enough length and width to support the entire biological sample.

[0053] In various embodiments of the present invention, the manufacturing method disclosed herein includes contacting the graphene layer with the support layer. In one embodiment, the graphene layer includes a protective polymer layer. As described herein, "transfer" or "contact" refers to face-to-face contact so as to coat the support layer with the graphene layer. In other embodiments, the manufacturing method includes drying the support layer with the graphene layer (e.g., at room temperature). The obtained support layer with the graphene layer is preferably dried in a time-controlled manner at room temperature, preferably dried between 15 minutes and 45 minutes, more preferably dried for any period of time in about 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes or 45 minutes. In various preferred embodiments, the support layer with the graphene layer is dried at room temperature for 30 minutes. As used herein, room temperature may include any temperature between 20°C and 25°C, and room temperature preferably means about 25°C. After the room temperature drying step, the support layer with the graphene layer can be heated at a temperature between 100°C and 200°C, including, for example, heating at any temperature of about 100°C, 120°C, 150°C, 170°C, 180°C and 200°C. In a preferred embodiment, the support layer of the graphene layer is heated to a temperature of about 150°C. The heating step can be performed at intervals of between 1 hour and 2 hours, 1 hour, 1.5 hours, and most preferably 2 hours. The heated product can be stored under vacuum conditions to cool, preferably for 24 hours. In various embodiments, the cooled product is then incubated in two to three organic solvents. In a preferred embodiment, the cooled product can be incubated in two organic solvents to remove the protective polymer layer from the graphene layer. In a further preferred embodiment, the incubation can be performed in two organic solvents in sequence. In other preferred embodiments, the cooled product can be first incubated in acetone, preferably incubated for 1 hour, and then incubated in isopropanol for 1 hour. In a further embodiment, the obtained support layer with a graphene monolayer can be blown dry with nitrogen (N2). In all the above embodiments, the support layer is preferably a support layer based on silica. The support layer based on silica preferably includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, and the support layer preferably includes a silica-based substrate, more preferably includes silica glass, which can be selected from 1×1 cm 2 Silicon dioxide coated sensors or glass microscope coverslips.

[0054] Those skilled in the art will appreciate that graphene can be transferred to a supporting layer by other methods. In one embodiment, the graphene used for transfer can be copper foil as a substrate, which can be removed by an etching solution during the transfer process. The etching solution comprises any one of ammonium persulfate, aluminum chloride, ferric chloride, and ferric nitrate, or a combination thereof. In a further embodiment, a direct synthesis method can be used to "transfer" a graphene layer to a supporting layer. A graphene layer is formed on a supporting layer using a gas or solid carbon source by magnetron sputtering, electron beam evaporation, or chemical vapor deposition. A preferred gaseous carbon source is any one of methane / hydrogen, ethylene / hydrogen, or acetylene / hydrogen. A preferred solid carbon source is any one of amorphous carbon, graphite, fullerene, and carbon nanotubes, or a combination thereof. In various embodiments, graphene may not be perfect during the manufacturing process. The graphene layer obtained may comprise oxygen, hydrogen, an amine group, a carboxyl group, or a metal ion. In these embodiments, unless the content of non-carbon elements makes the graphene unable to be modified with amphiphilic molecules, those graphene layers can be regarded as defect-free graphene layers.

[0055] According to a first aspect of the present invention, a method for manufacturing a device including a biofunctionalized graphene layer on a supporting layer as described herein also includes functionalization of a graphene layer performed with a synthetic compound of the present invention disclosed herein. As used herein, functionalization of graphene refers to reacting graphene with a functional group precursor to form a functionalized graphene layer. As used herein, the term "biofunctionalization" of graphene refers to forming a graphene layer to regulate the interaction and / or fixation of biomolecules with a graphene monolayer. Therefore, in some embodiments, a method for producing a graphene layer with customized surface properties by (bio) functionalization is provided herein. The method described herein can be advantageously performed without the need for severe oxidation and / or reduction of graphene in order to connect functional groups, which severe oxidation and / or reduction can introduce many hole defects on the graphene sheet or destroy other defects of the π electron cloud on the graphene, thereby reducing its conductivity and thus reducing its performance. In addition, the method for synthesizing functionalized graphene layers can be simplified, scalable and cost-effective without the need for long-term reactions, high-power ultrasonic treatments, surfactants, reactive graphite intercalation compounds and / or non-ideal electrochemical methods. Using the embodiments described herein, graphene layers containing a variety of functional groups can be synthesized in high yield. Such molecules can be used alone or in combination with nanoparticles or polymers. In a preferred embodiment, the functionalized graphene layer can be a single layer of (bio) functionalized graphene. In some cases, the (bio) functionalized graphene layer can be a multilayer of (bio) functionalized graphene. The functional group precursor can be any substance that can bond to graphene. The bonding of the functional group to graphene can be covalent or non-covalent, that is, covalent and / or non-covalent surface coatings. In the manufacturing method of the present invention, (bio) functionalization is a non-covalent surface coating. As used herein, "non-covalent" (bio)functionalization of graphene can be based on van der Waals or π-π interactions with any compound disclosed herein for (bio)functionalization of graphene layers. Non-covalent interactions are particularly suitable for use in the present invention because the extended π system of the graphene nanostructure has been shown to be uninterrupted, which means that properties (such as graphene plasmons, conductivity or mechanical strength) are not affected. Non-covalent (bio)functionalization of graphene with the amphiphilic biofunctionalizing compounds disclosed herein does not interrupt the electrical or mechanical properties of the graphene layer. In addition, non-covalent (bio)functionalization of graphene is obtained by direct contact of the amphiphilic biofunctionalizing compound with the graphene layer. The thickness of the (bio)functionalized layer on graphene according to the present invention is about at least 0.3 nm, between 0.3 nm and 0.5 nm, between 0.5 nm and 0.7 nm, between 0.7 nm and 0.8 nm, between 0.8 nm and 0.9 nm, between 0.9 nm and 1.0 nm or is at least 1.0 nm.In some embodiments, the thickness of (bio) functionalized layer on Graphene according to the present invention is approximately at the most 0.3nm, 0.5nm, 0.7nm, 0.8nm, 0.9nm, 1.0nm, 1.5nm, 2.0nm, 2.5nm, 3.0nm, 3.5nm, 4.0nm, 4.5nm or at the most 5.0nm. The thickness of (bio) functionalized layer on Graphene is as the detection lower limit of GIET device of the present invention.

[0056] Therefore, the favorable minimum distance above the graphene can be utilized to regulate the interaction and / or fixation of biomolecules on the graphene layer. As mentioned above, the minimum distance depends on the thickness of (biological) functionalized layer, and is 0.3nm, 0.5nm, 0.7nm, 0.8nm, 0.9nm, 1nm, 1.5nm, 2nm, 2.5nm, 3nm, 3.5nm, 4nm, 4.5nm or 5nm. Therefore, the detectable GIET region (sensitive GIET region) of the present invention can have the lower limit as the minimum distance.

[0057] In an exemplary embodiment, a method for (bio)functionalizing a graphene layer with an amphiphilic biofunctionalizing compound of the invention comprises using trisNTA-PEG-pyrene and BSA-HaloTag ligand conjugates, which are also provided by the invention. Figure 6 The label-free solid phase detection for trisNTA-PEG-pyrene shown in Figure 7 The label-free solid phase detection for BSA-HaloTag ligand conjugate shown in Figure 1 characterizes the formation of a (bio)functionalized layer of the amphiphilic compound on the graphene layer. In a preferred embodiment, the non-covalent interaction between the amphiphilic compound and the graphene layer is through the hydrophobic end of the compound. In various embodiments, by between 0.2 ng / mm 2 To 10.0ng / mm 2 Between 0.2ng / mm 2 To 1.0ng / mm 2 , between 1.0ng / mm 2 To 2.0ng / mm 2 Between, between 2.0ng / mm 2 Up to 2.5ng / mm 2 Between, between 2.5ng / mm 2 To 3.0ng / mm 2 Between, between 3.0ng / mm 2 To 3.5ng / mm 2 Between 3.5ng / mm 2 Up to 4.0ng / mm 2Between, between 4.0ng / mm 2 Up to 4.5ng / mm 2 Between 4.5ng / mm 2 To 5.0ng / mm 2 Between 5.0ng / mm 2 To 6.0ng / mm 2 Between, between 6.0ng / mm 2 To 8.0ng / mm 2 Between and between 8.0ng / mm 2 To 10.0ng / mm 2 The mass signal of any one between 1.0 ng / mm and 2.0 ng / mm is used to characterize the formation of the functionalized layer on the graphene. The mass signal variation of 1.0 ng / mm has been determined by calibration experiments. 2 The thickness corresponds to a shift of 1.2 nm in the interference minimum (1.5 order). The mass signal confirms the stable π-π interaction between the amphiphilic biofunctionalized compound and the graphene layer and determines the thickness of the covering layer. All the above embodiments of the present invention obtain a device having a support layer and a biofunctionalized graphene layer on the support layer.

[0058] The manufacturing method of the present invention comprises the step of applying an amphiphilic coating to a graphene layer to form a non-covalent surface coating on the graphene layer. In addition, according to a second aspect, the present invention also provides a new synthetic (amphiphilic) compound for biofunctionalization of graphene on a support layer. As described herein, the amphiphilic coating comprises an amphiphilic molecule having a hydrophobic group and a hydrophilic group, which may or may not be connected by a linking group.

[0059] As used herein, the term "amphiphilic molecule" generally refers to a molecule having a hydrophilic portion and a hydrophobic portion, which can self-assemble in water or another solvent to form a structure (such as a vesicle or micelle). As used herein, the term "hydrophilic group" means a polar group with a strong affinity for water, and the term "hydrophobic group" means a non-polar group with a low affinity for water and a high affinity for oil. The definition of hydrophilic group and hydrophobic group in the present invention may include all hydrophilic groups and hydrophobic groups known to those skilled in the art. According to the present invention, amphiphilic molecules are used to coat the graphene layer on the supporting layer, and this step is called (bio) functionalization, as described elsewhere herein. In such embodiments, amphiphilic molecules are also referred to as matrix molecules.

[0060] In various embodiments, the hydrophobic end is bound to the graphene layer. In some embodiments, the hydrophobic group bound to the graphene layer is a polycyclic aromatic hydrocarbon derivative. The polycyclic aromatic hydrocarbons mentioned herein include hydrocarbons composed of multiple aromatic rings that are fused, i.e., share one or more edges. Polycyclic aromatic hydrocarbons are also called polynuclear aromatic hydrocarbons ("PNA"). Therefore, the terms "polycyclic aromatic hydrocarbons", "PCA hydrocarbons", "PCA", "polynuclear aromatic compounds" or "PNA" are used interchangeably herein and refer to aromatic hydrocarbons with multiple fused aromatic rings. In a preferred embodiment, the polycyclic aromatic hydrocarbon used herein is pyrene. The term "pyrene" is known to those skilled in the art. It refers to a polycyclic aromatic hydrocarbon (PAH) composed of four fused benzene rings to form a planar aromatic system. The chemical formula is C 16 H 10 The general structure of pyrene is:

[0061]

[0062] In various embodiments, the hydrophobic group associated with the graphene layer is a cycloalkyne. As used herein, the term "cycloalkyne" refers to an unsaturated monocyclic hydrocarbon group having at least one endocyclic triple bond. Examples of cycloalkynes include, but are not limited to, cyclooctyne and cyclononyne. In a preferred embodiment, the cycloalkyne used herein is a cyclooctyne derivative. As used herein, "cyclooctyne" refers to an 8-membered ring containing a carbon-carbon triple bond. In a further preferred embodiment, the cyclooctyne derivative used herein is a benzo-fused cyclooctyne derivative. In a more preferred embodiment, the benzo-fused cyclooctyne derivative is dibenzocyclooctyne (DBCO). The term "DBCO" is known to those skilled in the art. It refers to a dibenzo-fused cycloalkyne compound consisting of an 8-membered ring. The chemical formula is C 16 H 12 The general structure of a DBCO is:

[0063]

[0064] In some embodiments, the hydrophobic group combined with the graphene layer is an aliphatic amine. As used herein, the term "aliphatic amine" refers to an amine compound in which the nitrogen atom of the amino group is connected to an aliphatic group rather than an aromatic ring, such as butylamine, cyclohexylamine, cyclohexanediamine, etc. As used herein, the term "aliphatic diamine" refers to a collection of aliphatic amine compounds containing two amino groups. In a preferred embodiment, the aliphatic amine used herein is a fatty amine derivative. As used throughout the specification, the term "fatty amine" means an aliphatic amine having at least one fatty alkyl chain, wherein the fatty alkyl chain is a saturated or unsaturated carbon. The fatty amine may contain more than one amine moiety. Suitable fatty amines are primary, secondary or tertiary fatty amines such as n-decylamine, n-dodecylamine, n-tetradecylamine, n-hexadecylamine, n-octadecylamine, oleylamine, (tallow alkyl)amine, (rapeseed alkyl)amine, (soy alkyl)amine, erucic acid amine, (cocoa alkyl)amine, N-(n-decyl)-trimethylenediamine, N-(n-dodecyl)-trimethylenediamine, N-(cocoa alkyl)-trimethylenediamine, N-(oleyl alkyl)-trimethylenediamine, N-(rapeseed alkyl)-trimethylenediamine, N-(soy alkyl)-trimethylenediamine, N-(tallow alkyl)-trimethylenediamine, N-erucic acid trimethylenediamine, N-(n-decyl)-N'-(3-aminopropyl)-1,3-propylenediamine, N-(n-dodecyl)-N'-(3-aminopropyl)-1,3-propylenediamine, oleyl-1,3-diaminopropane, N-(cocoa alkyl)-N'-(3-aminopropyl)-1,3-propylenediamine, N-(rapeseed alkyl)-N'-(3-aminopropyl)-1,3-propylenediamine, N-(soybean alkyl)-N'-(3-aminopropyl)-1,3-propylenediamine, N-oleyl-N'-(3-aminopropyl)-1,3-propylenediamine 1,3-propylenediamine, N-(3-aminopropyl)-1,3-propylenediamine, N-(tallow alkyl)-N'-(3-aminopropyl)-1,3-propylenediamine, N-erucyl-N'-(3-aminopropyl)-1,3-propylenediamine, N-(3-aminopropyl)-N'-[3-(9-decylamino)propyl]-1,3-propylenediamine, N-(3-amino-propyl)-N'-[3-(9-dodecylamino)propyl]-1,3-propylenediamine, N-(3-aminopropyl)-N'-[3-(9-(cocoa alkyl)amino)propyl]-1,3-propylenediamine, N-(3-aminopropyl)-N'-[3-(9-(cocoa alkyl)amino)propyl]-1,3-propylenediamine, 1,3-propanediamine, N-(3-aminopropyl)-N'-[3-(9-(rapeseed alkyl)amino)propyl]-1,3-propanediamine, N-(3-aminopropyl)-N'-[3-(9-(soybean alkyl)amino)propyl]-1,3-propanediamine, N-(3-aminopropyl)-N'-[3-(9-octadecenylamino)propyl]-1,3-propanediamine, N-(3-aminopropyl)-N'-[3-(9-(tallow alkyl)amino)propyl]-1,3-propanediamine, and N-(3-aminopropyl)-N'-[3-(9-erucylamino)propyl]-1,3-propanediamine.In a further preferred embodiment, the fatty amine derivative is an octadecylamine derivative. In a particularly preferred embodiment, the octadecylamine derivative is dioctadecylamine (DODA). The term "DODA" is known to those skilled in the art. It refers to secondary amines and fatty amine derivatives. The chemical formula is [CH3(CH2). 17 ]2NH. The general structure of DODA is:

[0065]

[0066] In various embodiments, the hydrophobic group bound to the graphene layer is a surface adhesion protein. As used herein, the term "surface adhesion protein" refers to a blocker that prevents nonspecific binding of the target analyte. In order to eliminate the residual binding capacity of the surface where the reaction is carried out, a protein-based blocker is generally used. Blockers can also stabilize the biomolecules bound to the surface and reduce nonspecific interactions. The surface adhesion protein can be any one of streptavidin, neutravidin, avidin, extracellular matrix protein or serum protein. In one embodiment, the extracellular matrix protein is fibronectin, laminin and collagen. Serum protein is one of albumin, macroglobulin and haptoglobin. In another embodiment, antibodies can be used as protein adhesion proteins on graphene. Antibodies are commonly used immunoglobulins comprising heavy chains and light chains. Antibodies can also be single-chain antibodies and nano antibodies known to those skilled in the art. In a preferred embodiment, the surface adhesion protein used herein is bovine serum albumin (BSA). As used herein, the term "BSA" is known to those skilled in the art. BSA is a serum albumin protein derived from cattle. The length of the full-length BSA precursor protein is 607 amino acids (AA). During secretion, the N-terminal 18-residue signal peptide is removed from the precursor protein, so the starting protein product contains 589 amino acid residues. An additional six amino acids are cleaved to produce a mature BSA protein containing 583 amino acids.

[0067] Therefore, in a particularly preferred embodiment, the hydrophobic group of the amphiphilic compound of the invention which is bound to the graphene layer is pyrene, dibenzocyclooctyne (DBCO) or dioctadecylamine (DODA) or bovine serum albumin (BSA).

[0068] In various embodiments, the hydrophilic group of the amphiphilic compound of the present invention may comprise an affinity capture moiety. As used herein, the term "affinity" refers to the equilibrium constant for the reversible binding of two agents and is expressed as K D. The affinity of a binding protein to a ligand (such as the affinity of an antibody to an epitope) can be, for example, from about 1000 nanomolar (nM) to about 0.1 nM, from about 100 nM to about 1 picomolar (pM), or from about 100 nM to about 1 femtomolar (fM). As used herein, "affinity capture" refers to the use of a portion specific for a target analyte to capture a target analyte. As used herein, the term "affinity capture moiety" refers to a molecule that binds to an affinity moiety binding partner (e.g., an epitope, a receptor, a ligand, etc.) to form an affinity binding pair. Similarly, the term "affinity moiety binding partner" refers to a portion or molecule that binds to an affinity moiety and is used interchangeably with the term "functional moiety". An affinity moiety can be synthetic, semisynthetic, or naturally occurring. Binding can occur through non-covalent interactions, such as electrostatic interactions, dipole-dipole interactions (e.g., Keesom interaction, London dispersion, and Debye interaction), dipole-π interactions, hydrogen bonds, van der Waals contacts, van der Waals / London dispersion, π-π stacking, and ionic bonds (e.g., salt bridges). Binding can occur through covalent interactions, forming, for example, ether bonds, ester bonds, amide bonds, phosphate bonds, Schiff bases, disulfide bonds, and thiol ester bonds. Exemplary affinity binding pairs that are independent of the target analyte include, for example, avidin or streptavidin and biotin; ligands and receptors; A or G protein binding regions of immunoglobulins and Fc regions; oligonucleotides and complementary sequences, such as polydeoxyadenylic acid and polydeoxythymidylic acid, or polydeoxyguanosine and polydeoxycytidylic acid; Ni-NTA (nitrilotriacetic acid, nickel salt) and polyhistidine tagging ligands, etc. In some embodiments, the "affinity capture moiety" and the "affinity moiety binding partner" are members of a specific binding pair. A specific binding pair includes two different moieties / molecules that specifically bind to each other by chemical or physical means. Specific binding partners include antigens / epitopes and antigen binding molecules thereof (e.g., antibodies), enzymes and their binding partners (including cofactors, inhibitors, and chemical moieties that promote reactions of enzymes), ligands (e.g., hormones, cytokines, growth factors, vitamins, etc.) and their receptors, complementary peptides, specific carbohydrate groups and lectins, antibiotics and their antibodies and naturally occurring binding proteins, complementary nucleotide sequences, aptamers and their targets, biotin and avidin (or streptavidin), etc. In addition, a specific binding pair may include members that are analogs of the original specific binding members, such as analyte analogs. Immune interaction specific binding members include antigens, antigen fragments and their epitopes and antigen binding molecules, such as, but not limited to, antibodies, antibody fragments and their variants (including fragments of variants), whether isolated or recombinantly produced.

[0069] In the present invention, the term "target analyte capture moiety" refers to any of the affinity capture moieties described herein that are associated with a specific target analyte, such as a protein capture moiety, a nucleotide capture moiety, a chelating agent, and the like.

[0070] According to the present invention, the term "nucleic acid affinity capture moiety" includes any of the affinity capture moieties described herein, for example, including but not limited to binding proteins, complementary nucleotide sequences, aptamers and their targets, biotin and avidin (or streptavidin), etc. Each alternative represents a separate embodiment of the present invention. In the present invention, the protein affinity capture moiety can be an enzymatic protein capture ligand, such as 0 6 -benzylguanine derivatives or O 2 - an enzymatic protein-trapping ligand of a benzylcytosine derivative; the enzymatic protein-trapping ligand may preferably be an alkyl halide derivative, more preferably a alkyl chloride derivative; or a chelating agent, preferably a carboxylic acid-based chelating agent, more preferably a diacetic acid- or triacetic acid-based chelating agent.

[0071] In one embodiment, the affinity capture moiety is 6 -benzylguanine derivative, i.e., SNAP tag ligand. SNAP-tag is a 182-residue polypeptide (19.4 kDa) that can be specifically and covalently tagged with a SNAP tag ligand. In a particularly preferred embodiment, the affinity capture moiety is a HaloTag ligand. In a further preferred embodiment, the enzymatic protein capture ligand may be a 6-chlorohexanol derivative, preferably chlorohexane-OEG2-amine. The HaloTag used herein is a self-labeling protein tag that can be fused to a target protein, thereby acting as a functional part. HaloTag may be a 297-residue peptide (33 kDa) derived from a bacterial enzyme that is designed to covalently bind to a synthetic ligand (a HaloTag ligand that can be fused to a target protein through a functional part).

[0072] In various embodiments, the "affinity capture moiety" may be a chelator. As used herein, the term "chelator" is a compound that coordinates with a metal to form a chelate. Chelators include molecules containing two or more electron donor atoms that can form a coordination bond with a single metal ion. The term "chelator" should be understood to include chelators and salts thereof. In a preferred embodiment, the chelator used herein is a carboxylic acid-based chelator, more preferably a diacetic acid or triacetic acid-based chelator. In one embodiment, the diacetic acid-based chelator is iminodiacetic acid (IDA), which may or may not be preloaded with zinc ions. In a preferred embodiment, the chelator used herein is a reagent based on nitrilotriacetic acid (NTA), which may or may not be preloaded with metal ions. These metal ions are any one of nickel ions, zinc ions, cobalt ions, and copper ions. According to the present invention, an exemplary affinity binding pair (i.e., a functional portion) of NTA is a polyhistidine tag. As used herein, the term "polyhistidine tag" refers to a linear sequence of histidine residues that allows affinity-based immobilization of peptides and / or proteins. The polyhistidine tag may contain any of 6, 7, 8, 9, 10, 11, 12, 13, 14 consecutive histidine residues. In various embodiments, the chelating agent is a multivalent sequestering agent.

[0073] As further described herein, the hydrophobic group and the hydrophilic group may be connected by a linking group, which is preferably a polymer, more preferably poly(ethylene glycol) (PEG).

[0074] As used herein, the term "linking group" means a part that connects at least two other parts (such as a hydrophobic group and a hydrophilic group in an amphiphilic molecule) together. A variety of linking groups can be used, including biodegradable linking groups and biopolymers. The linking groups described herein specifically include polymers, such as macromolecular structures, preferably poly (ethylene glycol) (referred to as PEG). The linking group used herein preferably comprises repeating units of PEG. The number of repeating units is an integer of 1-500, preferably in the range of 50 to 500, at least 400, preferably at least 200, more preferably at least 100, and even more preferably at least 50. PEG can be a branched PEG. The number of branches can be 3, 4, 5, 6, 7 and 8. At least two of the ends of the branched PEG can be covalently conjugated to a hydrophilic group and a hydrophobic group, respectively. In a preferred embodiment, the amphiphilic molecules of the present invention, wherein the hydrophilic group and the hydrophobic group are connected by a linking group, include amphiphilic molecules in which the hydrophobic group is a polycyclic aromatic hydrocarbon derivative, preferably pyrene. In other preferred embodiments, the amphiphilic molecules of the present invention wherein the hydrophilic group and the hydrophobic group are linked by a linking group include amphiphilic molecules wherein the hydrophobic group is a cycloalkyne, preferably a cyclooctyne derivative, even more preferably a benzo-fused cyclooctyne derivative and even more preferably dibenzocyclooctyne (DBCO).

[0075] According to any of the above embodiments, the amphiphilic molecule can be considered as a matrix molecule having a hydrophobic group and a hydrophilic group. The hydrophobic group may include any of the following compounds: a polycyclic aromatic hydrocarbon derivative, preferably pyrene; a cycloalkyne, preferably a cyclooctyne derivative, more preferably a benzo-fused cyclooctyne derivative; a surface adhesion protein, preferably bovine serum albumin. The hydrophobic group and the hydrophilic group may be connected by or without a linking group, wherein the linking group is preferably a polymer, more preferably wherein the linking group is poly(ethylene glycol) (PEG).

[0076] In various embodiments, the amphiphilic molecules can be considered as matrix molecules, wherein the hydrophilic groups of the amphiphilic compounds used for the (bio)functionalization of the graphene layer of the present invention do not contain protein affinity capture parts. The matrix molecules are capable of forming a self-assembled monolayer. The amphiphilic molecules include lipids, preferably 1,2-diacyl-sn-glyceryl-3-phosphocholine, more preferably 1,2-dimyristoyl-sn-glyceryl-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glyceryl-3-phosphocholine (DPPC), 2-dilauroyl-sn-glyceryl-3-phosphocholine (DLPC), 1,2-dioleoyl-sn-glyceryl-3-phosphocholine (DOPC), 1,2-distearoyl-sn-glyceryl-3-phosphocholine (DP ... Choline (DSPC) and 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC), 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (MSPC), 1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (PMPC), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (PSPC), 1-stearoyl-2-myristoyl-sn-glycero-3-phosphocholine (SMPC) ), 1-stearoyl-2-palmitoyl-sn-glyceryl-3-phosphocholine (SPPC), 1-myristoyl-2-oleoyl-sn-glyceryl-3-phosphocholine (MOPC), 1-palmitoyl-2-oleoyl-sn-glyceryl-3-phosphocholine (POPC), 1-stearoyl-2-oleoyl-sn-glyceryl-3-phosphocholine (SOPC); and / or 1,2-diacyl-sn-glyceryl-3-phosphoethanolamine, more preferably 1,2-dimyristoyl- sn-glyceryl-3-phosphoserine (DMPS), 1,2-dipalmitoyl-sn-glyceryl-3-phosphoserine (DPPS), 1,2-dioleoyl-sn-glyceryl-3-phosphoserine (DOPS), 1,2-distearoyl-sn-glyceryl-3-phosphoserine (DSPS), 1-palmitoyl-2-oleoyl-sn-glyceryl-3-phosphoserine (POPS) and 1-stearoyl-2-oleoyl-sn-glyceryl-3-phosphoserine (SOPS). The matrix lipid molecules are exemplified in Examples 2, 3 and 4. These matrix lipid molecules can be neutrally charged or negatively charged or a mixture thereof. In various embodiments, the molar ratio of negatively charged lipids in the mixture of negatively charged lipids and neutral lipids is in the range of 0% to 20%, 1%, 2%, 3%, 4%, preferably 5%. In various embodiments, the molar ratio of the negatively charged lipid in the mixture of negatively charged lipid and neutral lipid is 10%, 15% or 20%.In a preferred embodiment, the molecule is 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS) or a binary mixture thereof. In such embodiments, the molar ratio of DOPC / DOPS is 95:5.

[0077] In various embodiments, the graphene layer is functionalized with a mixture of matrix molecules comprising an affinity capture moiety according to any of the embodiments described herein and matrix molecules without an affinity capture moiety according to any of the embodiments described herein. In various embodiments, the molar ratio of the matrix molecules with affinity capture moieties and without affinity capture moieties for (bio)functionalization of graphene may be in the range of between 0.001 and 0.999, preferably between 0.01 and 0.99. In other preferred embodiments, the molar ratio may be 50:50, as shown in Example 12 for trisNTA-PEG-pyrene / mPEG-pyrene. In other preferred embodiments, the molar ratio may be 95:5, as shown in Example 5 for DOPC / trisNTA DODA.

[0078] In various embodiments, the present invention provides methods for synthesizing amphiphilic compounds for graphene biofunctionalization, as shown in Examples 10, 11, 13, and 14. In various embodiments, the amphiphilic compound comprising an affinity capture portion in the hydrophilic group is trisNTA-PEG-DBCO, trisNTA-PEG-pyrene, trisNTA-DODA, BSA-HaloTag ligand conjugates, and BSA-biotin conjugates. In a preferred embodiment, the amphiphilic compound that does not comprise an affinity capture portion in the hydrophilic group may be 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS) or a binary mixture thereof. In various embodiments, the amphiphilic molecule according to any of the embodiments described herein may be synthesized as a monolayer or a bilayer. The synthesis of a monolayer and / or a bilayer may be detected by a mass change. Preferably, the mass change detected for the bilayer is twice the mass change detected for the monolayer. In an exemplary embodiment, 5.0 ng / mm 2 The characteristic mass change of the double layer formation and 2.5ng / mm 2 The precise half-mass change that characterizes monolayer formation is shown in Figure 2A. In various exemplary embodiments, the present invention provides methods for synthesizing DOPC liposomes or binary mixtures of DOPS and DOPC liposomes for biofunctionalization of graphene. Anionic DOPS is preferably included in the mixture at 5 mol%. Preferably, biofunctionalization with DOPS ensures vertical deposition of negatively charged biomolecules on the graphene layer.

[0079] In a third aspect, the present invention provides a device having a support layer and a [bio]functionalized graphene layer on the support layer, which device can be obtained according to any embodiment of the embodiments of the first aspect of the present invention and includes any embodiment of the embodiments of the second aspect of the present invention.

[0080] As disclosed herein, the device includes a graphene layer coated on a support layer. In various embodiments of the present invention, the support layer of the device provides a suitably strong foundation for the biofunctionalized graphene layer. In a preferred embodiment, the support layer of the present invention is a silica support layer. The silica support layer preferably includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, wherein the support layer preferably includes a silica-based substrate, more preferably includes silica glass, which may be, for example, 1×1 cm 2 Silica coated sensors or glass microscope coverslips. In preferred embodiments, the silica used herein is in the form of silica coated sensors. In a further preferred embodiment, the silica coated sensors are used for reflection interference spectroscopy and total internal reflection fluorescence spectroscopy detection (RIfs-TIRFs). In other preferred embodiments, the silica substrate used herein is a glass microscope coverslip.

[0081] In various embodiments, the methods and GIET devices of the present invention have a graphene layer functionalized with the amphiphilic compounds of the present invention disclosed herein. Preferably, the methods and GIET devices of the present invention have a graphene layer on a silica support layer, which is functionalized with any of the amphiphilic molecules according to any of the embodiments described above in the context of the second aspect of the present invention, these amphiphilic molecules particularly include DOPC liposomes or a binary mixture of DOPC and DOPC liposomes, or trisNTA-PEG-DBCO, trisNTA-PEG-pyrene, trisNTA-DODA, BSA-HalTag ligand conjugates and / or BSA-biotin conjugates. Each alternative represents a separate embodiment of the present invention.

[0082] In other embodiments, the present invention provides a kit comprising a device made according to the above embodiments. The device can be used as a graphene-induced energy transfer device.

[0083] In a fourth aspect, the present invention provides a method for calibrating graphene induced energy transfer (GIET) versus distance using the apparatus disclosed herein. The gapless band structure of graphene and the linear dispersion relations near the corners of the Brillouin zone result in a frequency-independent absorption of light that is governed only by the fine structure constant (α≈1 / 137). Thus, in the visible and near-infrared spectral regions, this material, which is only one atom thick, absorbs πα≈2.3% of the light. Thus, graphene behaves as an extraordinary energy absorber and a unique receptor system. Fluorescent dyes placed close to graphene are strongly quenched, and their removal from the graphene restores fluorescence. Experiments have demonstrated that energy transfer from a molecule (a single dipole) to graphene (a "2D array of dipoles") depends largely on the distance d between the two and is related to d -4 is proportional to. Although the distance dependence is well known, there are different reports on the d0 value, which represents the distance at which the quenching efficiency is 50%. The calibration method provided herein uses both fluorescence intensity measurement (e.g., total internal reflection mode) and fluorescence lifetime measurement to determine the sensitive graphene-induced energy transfer zone. In a preferred embodiment, the method utilizes a manufacturing device as described elsewhere herein, wherein the graphene layer is coated on a support layer. In a preferred embodiment, the support layer of the present invention is a silica support layer. The silica support layer preferably includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, wherein the support layer preferably includes a silica-based substrate, more preferably includes silica glass, and the silica glass may be 1×1 cm 2 Silica coated sensor or glass microscope cover glass. In a preferred embodiment, the silica used herein is in the form of a silica coated sensor. In a further preferred embodiment, the silica coated sensor is used for reflection interference spectroscopy and total internal reflection fluorescence spectroscopy detection (RIfs-TIRFs). In other preferred embodiments, the silica substrate used herein is a glass microscope cover glass. In other embodiments, the present invention provides a device in which the graphene layer is (bio) functionalized with an amphiphilic compound synthesized according to the present invention. Preferably, the device provided by the present invention includes a graphene layer on a silica support layer, and the graphene layer is (bio) functionalized according to any of the amphiphilic molecules of any of the embodiments described above in the context of the second aspect of the present invention, and these amphiphilic molecules include DOPC liposomes or a binary mixture of DOPS and DOPC liposomes, or any of trisNTA-PEG-DBCO, trisNTA-PEG-pyrene, trisNTA-DODA, BSA-HaloTag ligand conjugates and / or BSA-biotin conjugates. Each alternative represents a separate embodiment of the present invention.

[0084] In various embodiments of the present invention, biomolecules are used as nanorulers for graphene induced energy transfer (GIET) versus distance calibration methods. In preferred embodiments, single-stranded DNA (ssDNA) is used as a scaffold for the nanoruler. Preferably, the ssDNA nanoruler comprises an "anchor" strand and a "probe" strand, wherein the two strands are hybridized. In preferred embodiments, the "anchor" strand comprises at least a common 20-mer sequence at the 5' end and a cholesterol modification at the 3' end, preferably, the cholesterol modification contains a linking group, preferably a polyethylene glycol linking group. Preferably, the anchor strand is connected to a non-covalently modified graphene layer coated on a silica support layer via the cholesterol modification at the 3' end. In other preferred embodiments, the "probe" strand comprises at least a common 20-mer sequence complementary to the "anchor strand". Preferably, the ssDNA used as a nanoruler comprises a fluorescent label. In preferred embodiments, the fluorescent label is located on the "probe" strand. As used herein, the term "fluorescent label" generally refers to a molecule that emits light at an emission wavelength after the label is excited with light of an excitation wavelength. The emission of fluorescent markers covers detectable ultraviolet light, the entire visible light spectrum and detectable near-infrared range. Preferably, the spectral range of emission is within the range of 300nm to 2500nm. More preferably, the spectral range of emission is within the range of 350nm to 2000nm. Most preferably, the spectral range of emission is within the range of 400nm to 800nm. Examples of specific materials that can be used as fluorescent markers include organic dyes, such as cyanine dyes, xanthene dyes, rhodamine dyes, fluorescein and fluorescein derivatives and chelates of rare earth metal ions. As used herein, "fluorescent marker" also means an organic molecule with a fluorescent moiety and a connecting moiety, so that the connecting moiety allows the fluorescent moiety to be covalently linked to the target functional group. Some considerations associated with the construction and use of fluorescent markers include the stability of the bond between the fluorescent moiety and the connecting moiety, the influence of the connecting moiety on the fluorescence characteristics before and after being connected to the target functional group, the stability of the bond between the fluorescent moiety and the target functional group (i.e., the intensity of the connecting moiety after connection), the reactivity of the connecting functional group with the target functional group, etc. When multiple fluorescent labels are required, each with different fluorescence properties (such as non-overlapping emission peaks), selecting a label for a particular application can become difficult and often requires a trade-off between the desired properties of the available fluorescent labels.

[0085] For GIET measurement, the analyte or the interaction partner of the analyte can be fluorescently labeled. The fluorescent chromophore used to label nucleotides can be an organic dye as described herein. The fluorescent chromophore used to label proteins can be an organic dye molecule and a fluorescent protein (FP). FP includes green fluorescent protein (e.g., GFP, mNeon), blue fluorescent protein (e.g., BFP, CFP), red fluorescent protein (e.g., mCherry, TagRFP), infrared fluorescent protein (URFP).

[0086] In a preferred embodiment, the fluorescent label is 6-carboxyfluorescein (FAM). In a preferred embodiment, any number of ssDNAs between 20-mer and 50-mer nucleotides can be used. For example, four ssDNAs including 20-mer, 25-mer, 35-mer and 50-mer nucleotides are used, such as Figure 1 A. A method for calibrating GIET relative to distance may include obtaining the fluorescence intensity of a biomolecule. In an exemplary embodiment, in (I GIET ) and on the separate silica shown in (I0) there is a ssDNA probe chain. The fluorescence intensity ratio on graphene and silica allows the GIET efficiency related to distance (d) to be quantified. According to various embodiments of the present invention, the detectable GIET region (sensitive GIET region) is between 1nm and 50nm, preferably between 1nm and 40nm, more preferably between 1nm and 30nm, and even more preferably between 1nm and 25nm. In other preferred embodiments, the GIET sensitivity in the detectable GIET region may be between 1.0nm and 3.0nm, between 1.5nm and 3.0nm, between 2.0nm and 3.0nm, or between 2.5nm and 3.0nm. The GIET sensitivity in the detectable GIET region may be particularly less than about 1.7nm, 1.6nm, 1.5nm, 1.4nm, 1.3nm or 1.2nm. These results are shown in Figure 1 In Figure B, based on the verified intensity-based GIET curve, I GIET The / I0 ratio is 140 times that at 1 nm, 9.2 times that at 5 nm, 2.2 times that at 10 nm, and 1.1 times that at 20 nm. Using the intensity ratio, the detection sensitivity at 1 nm is 15 times higher than at 5 nm, 64 times higher than at 10 nm, and 127 times higher than at 20 nm.

[0087] According to a fifth aspect of the present invention, the means and methods disclosed herein for biofunctionalized graphene on a support layer can be used as a device, in particular, for DNA hybridization assays, including clinical PCR (polymerase chain reaction) tests of target genomic sequences. In various embodiments of the present invention as shown in Examples 7, 8 and 9, fluorescence quenching and / or dequenching by DNA hybridization allows DNA or RNA hybridization assays to be performed using GIET. DNA or RNA hybridization assays can be performed by fluorescence intensity measurement (e.g., total internal reflection mode) or fluorescence lifetime measurement. The method utilizes a manufacturing device as described elsewhere herein, wherein a graphene layer is coated on a support layer. In a preferred embodiment, the support layer of the present invention is a silica support layer. The silica support layer preferably includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material, wherein the support layer preferably includes a silica-based substrate, more preferably includes silica glass, and the silica glass may be 1×1 cm 2 Silica coated sensors or glass microscope coverslips. In other preferred embodiments, the silica substrate used herein is a glass microscope coverslip. In other embodiments, the invention provides a device in which the graphene layer is (bio) functionalized with an amphiphilic compound synthesized according to the invention. The method of fluorescence quenching and dequenching by GIET is particularly suitable for replacing molecular beacon probes or other quenching-based probes used in polymerase chain reaction (PCR) detection. For example, the method can be used for real-time PCR quantification or multiplex PCR assays to detect target genomic sequences.

[0088] According to a sixth aspect of the present invention, methods for determining the structure and / or dynamics of biomolecules are provided herein. As used herein, the term "biomolecule" includes any type of biomolecules for which (quantitative) structure, function and / or activity may be required, including but not limited to peptides, proteins, nucleic acids, sugars, monosaccharides and polysaccharides, lipids, lipoproteins, whole cells, etc., or a variety of enzymes, organic and inorganic chemicals, other sensitive biopolymers including DNA and RNA, and complex systems including the whole or fragments of plant, animal and microbial cells.

[0089] As used herein, the term "protein" refers to a polypeptide with a specific secondary and tertiary structure, which can interact with another molecule, and in particular with other biomolecules including other proteins, DNA, RNA, lipids, metabolites, hormones, chemokines and / or small molecules. As used herein, the term "polypeptide" refers to an organic linear, cyclic or branched polymer composed of two or more amino acid monomers and / or their analogs. The term "polypeptide" includes amino acid polymers of any length, including full-length proteins and peptides, as well as analogs and fragments thereof. Polypeptides of three or more amino acids are also referred to as protein oligomers, peptides or oligopeptides. In particular, the terms "peptide" and "oligopeptide" generally refer to polypeptides with less than 100 amino acid monomers. In particular, in proteins, polypeptides provide the primary structure of proteins, wherein the term "primary structure" of proteins refers to the sequence of amino acids covalently linked in a polypeptide chain to form a polypeptide polymer. Protein "sequence" refers to the order of amino acids that form the primary structure. The covalent bonds between amino acids within the primary structure may include peptide bonds or disulfide bonds, as well as other bonds that can be identified by technicians. Polypeptide in the sense of the present disclosure is usually composed of a linear chain of α-amino acid residues covalently linked by a peptide bond or a synthetic covalent bond. Based on the properties of the free radicals on each end, the two ends of the linear polypeptide chain containing the terminal residue and the adjacent segment are referred to as the carboxyl terminal (C-terminal) and the amino terminal (N-terminal). Unless otherwise indicated, the counting of residues in the polypeptide is carried out in the order from the N-terminal (NH2-group) (the end is the end where the amino group is not included in the peptide bond) to the C-terminal (-COOH group) (the end is the end where the COOH group is included in the peptide bond). In some cases where the protein is a synthetic protein in at least a portion of a polymer, two or more amino acid monomers and / or their analogs are connected by chemically mediated condensation of an organic acid (-COOH) and an amine (-NH2) to form an amide bond or a "peptide" bond.

[0090] As used herein, the term "amino acid" refers to an organic compound consisting of an amine and a carboxylic acid functional group and a side chain specific to each amino acid. In particular, an amino acid refers to an organic compound consisting of an amine (-NH2) and a carboxylic acid (-COOH) and a side chain specific to each amino acid connected to the α carbon. Different amino acids have different side chains and have unique properties, such as charge, polarity, aromaticity, reduction potential, hydrophobicity, and pKa. Amino acids can be covalently linked to form a polymer by a peptide bond through a reaction between the amine group of the first amino acid and the carboxylic acid group of the second amino acid. In the sense of the present invention, amino acids refer to any of twenty naturally occurring amino acids, non-natural amino acids, and include D and L optical isomers.

[0091] As used herein, the term "ligand" refers to a moiety capable of covalently or otherwise chemically binding to a target compound.

[0092] As used herein, the term "lipid" includes mono-, di- and triglycerides of fatty acids, sucrose esters and propylene glycol esters of fatty acids, and the like, as well as waxes, phospholipids and glycolipids, and mixtures thereof.

[0093] As used herein, the term "carbohydrate" includes polysaccharides (eg, starch and dextrin) and sugars (eg, sucrose, lactose, maltose, glucose, and fructose) that are metabolized to energy when hydrolyzed.

[0094] As used herein, the term "nucleic acid" may include any polymer or oligomer of pyrimidine and purine bases, preferably cytosine, thymine and uracil, and adenine and guanine, respectively. See Albert L. Lehninger, PRINCIPLES OF BIOCHEMISTRY, pp. 793-800 (Worth Pub, 1982). In fact, the present invention contemplates any deoxyribonucleotide, ribonucleotide or peptide nucleic acid component and any chemical variant thereof, such as methylated, hydroxymethylated or glycosylated forms of these bases. Polymers or oligomers may be heterogeneous or homogeneous in composition, and may be isolated from naturally occurring sources or may be artificially or synthetically produced. In addition, nucleic acid may be DNA or RNA or a mixture thereof, and may exist permanently or temporarily in single-stranded or double-stranded form (including homoduplex, heteroduplex and hybrid state).

[0095] As used herein, "aptamer" refers to a nucleic acid with specific binding affinity for a target molecule. It is recognized that affinity interactions are a matter of degree; however, in this case, the "specific binding affinity" of an aptamer to its target means that the affinity of the aptamer to bind to its target is generally much higher than the affinity of the aptamer to bind to other components in the test sample. "Apptamers" are a set of copies of one or more nucleic acid molecules with a specific nucleotide sequence. An aptamer may include any suitable number of nucleotides, including any number of chemically modified nucleotides. "Apptamers" refer to more than one set of such molecular groups. Different aptamers may have the same or different numbers of nucleotides. An aptamer may be DNA or RNA or a chemically modified nucleic acid, and may be single-stranded, double-stranded, or contain a double-stranded region, and may include higher-order structures. An aptamer may also be a photoaptamer, in which a photoreactive or chemically reactive functional group is included in the aptamer to allow it to be covalently linked to its corresponding target. Any of the aptamer methods disclosed herein may include the use of two or more aptamers that specifically bind to the same target molecule. As further described below, an aptamer may include a tag. If the aptamer includes a tag, all copies of the aptamer need not have the same tag. In addition, if different aptamers each include a tag, these different aptamers can have the same tag or different tags.

[0096] Immobilization and capture of biomolecules are characteristics of methods for determining the structure and / or dynamics of biomolecules. In various embodiments, the method for immobilizing biomolecules to a graphene layer requires an affinity capture portion attached to a hydrophilic group of any of the amphiphilic molecules of the present invention disclosed herein. In various embodiments, the method for immobilizing biomolecules to a graphene layer requires a functional portion attached to the biomolecule. In various embodiments, the method for immobilizing biomolecules to a graphene layer requires an affinity capture portion attached to a hydrophilic group of any of the amphiphilic molecules of the present invention and a functional portion attached to the biomolecule. As used herein, the term "functional portion" refers to a chemical group or molecule having a certain biological, chemical, therapeutic and / or diagnostic function in vitro or in vivo. The functional portions used in the present invention are described elsewhere herein. In the present invention, the method for determining the structure and / or dynamics of biomolecules requires a hydrophilic group of an amphiphilic compound of the present invention, which comprises an affinity capture portion attached to a functional portion of a biomolecule for immobilizing the biomolecule on the surface of a functionalized graphene layer of a device.

[0097] In various embodiments, the "affinity capture moiety" is an enzymatic protein capture ligand, preferably a haloalkane derivative, more preferably a chloroalkane derivative. In a more preferred embodiment, the affinity capture moiety is a HaloTag ligand, and the functional moiety is HaloTag. The HaloTag used herein is a self-labeling protein tag. HaloTag is a 297-residue peptide (33 kDa) derived from a bacterial enzyme that is designed to covalently bind to a synthetic ligand (i.e., a HaloTag ligand that can be fused to a target protein). HaloTag can be selected from many available ligands known to those skilled in the art. In a further preferred embodiment, the enzymatic protein capture ligand is a 6-chlorohexanol derivative, preferably chlorohexane-OEG2-amine.

[0098] As described elsewhere herein, the "affinity capture moiety" may be a chelator. As used herein, the term "chelator" is a compound that coordinates with a metal to form a chelate. Chelators include molecules containing two or more electron donor atoms that can form a coordination bond with a single metal ion. The term "chelator" should be understood to include chelators and salts thereof. In a preferred embodiment, the chelator used herein is a carboxylic acid-based chelator, more preferably a diacetic acid or triacetic acid-based chelator. In a preferred embodiment, the chelator used herein may be a nitrilotriacetic acid (NTA)-based reagent. Therefore, the functional part on the biomolecule is a polyhistidine tag. As used herein, the term "polyhistidine tag" refers to a linear sequence of histidine residues that allows affinity-based immobilization of peptides and / or proteins. The polyhistidine tag may contain any of 6, 7, 8, 9, 10, 11, 12, 13, 14 consecutive histidine residues.

[0099] In one exemplary embodiment, the biomolecule is immobilized on the device of the present invention using the hexahistidine tagging functional moiety on the biomolecule via the affinity capture moiety tris-NTA on the hydrophilic group of the amphiphilic molecule on the functionalized graphene layer. In such exemplary embodiments, the biomolecule is as described in Examples 12 and Figure 6 (Stages III and IV) Monomeric enhanced green fluorescent protein (H6GFP) is shown.

[0100] In another exemplary embodiment, the biomolecule is immobilized on the device of the present invention using the HaloTag functional part on the biomolecule, through the affinity capture part HaloTag ligand on the hydrophilic group of the amphiphilic molecule on the functionalized graphene layer. In such exemplary embodiments, the biomolecule is an anti-GFP DARPin as shown in Example 15.

[0101] In order to determine the structure and / or dynamics of the biomolecule, after the biomolecule is fixed to the functionalized graphene layer of the device, the next step is to determine the axial size of the biomolecule by fluorescence quenching. As used herein, the term "fluorescence quenching" means the reduction of fluorescence due to the photochemical destruction of the fluorescent substance by irradiating it with excitation light. As used herein, the term "fluorescent label" generally refers to a molecule that emits light at an emission wavelength after being labeled with light excitation of an excitation wavelength. The emission of the fluorescent label covers detectable ultraviolet light, the entire visible light spectrum, and a detectable near-infrared range. Preferably, the spectral range of emission is in the range of 300nm to 2500nm. More preferably, the spectral range of emission is in the range of 350nm to 2000nm. Most preferably, the spectral range of emission is in the range of 400nm to 800nm. Examples of specific materials that can be used as fluorescent labels include organic dyes, such as cyanine dyes, xanthene dyes, rhodamine dyes, fluorescein and fluorescein derivatives, and chelates of rare earth metal ions. As used herein, "fluorescent label" also means an organic molecule having a fluorescent moiety and a linking moiety, such that the linking moiety allows the fluorescent moiety to be covalently linked to a target functional group. Some considerations associated with the construction and use of fluorescent labels include the stability of the bond between the fluorescent moiety and the linking moiety, the effect of the linking moiety on the fluorescence properties before and after connection to the target functional group, the stability of the bond between the fluorescent moiety and the target functional group (i.e., the strength of the linking moiety after connection), the reactivity of the linking functional group with the target functional group, etc. When multiple fluorescent labels are required, each having different fluorescent properties (such as non-overlapping emission bands), it becomes very difficult to select a label for a specific application, and it is usually necessary to balance the desired properties of the available fluorescent labels.

[0102] For GIET measurement, the analyte or the interaction partner of the analyte can be fluorescently labeled. The fluorescent chromophore used to label nucleotides can be an organic dye as described herein. The fluorescent chromophore used to label proteins can be an organic dye molecule and a fluorescent protein (FP). FP includes green fluorescent protein (e.g., GFP, mNeon), blue fluorescent protein (e.g., BFP, CFP), red fluorescent protein (e.g., mCherry, TagRFP), infrared fluorescent protein (URFP).

[0103] As used herein, the term "axial dimension" is defined as the nominal longitudinal dimension (nm) of a biomolecule. In an exemplary embodiment, as in Examples 5 and Figure 2 A. Figure 2 B and Figure 3 The axial size of the H6-NB::GFP complex was determined as shown.

[0104] In other embodiments, the axial conformational changes of biomolecules can be determined. As used herein, the term "conformational change" refers to a change in the molecular structure of a substance. The term is intended to include changes in the structure of a single molecule or a molecular aggregate. As used herein, when the term "conformational change" is used for a protein, it means at least one change in the structure of the protein, a change in the shape of the protein, or a change in the arrangement of parts of the protein. The parts of the protein can be atoms that change their relative position, for example, due to rotation around one or more chemical bonds that occur between atoms in the molecular structure. These parts can also be regions of secondary, tertiary or quaternary structure. The parts of the protein can also be domains of macromolecules, such as those domains generally known in the relevant art.

[0105] In an exemplary embodiment, as in Example 6 and Figure 4 A and Figure 4 Conformational changes of ssDNA are measured as shown in B. In a preferred embodiment, axial conformational changes greater than 10 nm are quantified.

[0106] According to the method and composition of the present invention, it has been found that GIET has an extended sensitive distance of up to 50nm nanometer-level sensitivity compared to 10nm of FRET. According to the present invention, GIET only requires a single fluorescent labeling of the target biomolecule, unlike the FRET measurement, which requires double labeling of the donor and acceptor on the protein. Therefore, the correction of the labeling degree and spectral leakage necessary for FRET measurement is avoided. According to the method of the present invention, the high transparency of graphene makes the lifetime determination by GIET very quickly completed within a few seconds, while MIET usually requires 10 minutes to collect enough photons for accurate determination of fluorescence lifetime.

[0107] The present invention also demonstrates that due to the high transparency of graphene to visible light, fluorescence intensity-based GlET can be performed in the form of total internal reflection fluorescence detection. Therefore, according to the present invention, highly sensitive single-molecule GIET can be achieved to obtain structural fluctuations of single biomolecules hidden by assembly measurements. According to aspects of the present invention, biofunctionalization of graphene by trisNTA-PEG-pyrene or trisNTA-PEG-DBCO is reversible after alcohol washing. In addition, His-tagged proteins are reversibly bound to graphene by trisNTA.

[0108] In the seventh aspect of the present invention, the methods, compounds and devices disclosed herein can be used for screening, analysis and / or diagnostic applications. The means and methods of the present invention, including novel amphiphilic compounds trisNTA-PEG-DBCO, trisNTA-PEG-pyrene and BSA-HaloTag ligand conjugates for biofunctionalization of graphene, can be used to detect the structure and activity of a large number of biomolecules (DNA and proteins are used as examples herein). The means and methods disclosed herein for biofunctionalized graphene on a support layer can be used as devices, in particular, for DNA hybridization assays, including clinical PCR (polymerase chain reaction) tests of target genomic sequences. In addition, these means and methods can be used as devices for structural dynamics determination of pharmaceutically important transmembrane receptors, cytokine receptors, GPCRs or soluble His-tagged proteins. These GIET devices will become core components of diagnostic kits and will be widely used in scientific research and drug screening (see quantitative PCR instruments and commercialization Chip). The kit reports drug-induced structural changes in protein receptors as an indicator of its effectiveness. By integrating the GIET device in fluid systems, sampling systems, etc., automated large-scale screening of target genes and candidate drugs can be achieved.

[0109] Example

[0110] Embodiments of the means and methods of the present invention are illustrated in the following examples. These examples are for illustrative purposes only and should not be construed as limiting the scope of the present invention to any extent.

[0111] Example 1 Formation of a graphene monolayer on a silicon dioxide substrate

[0112] The silicon dioxide-based substrate is used to form a graphene monolayer thereon. The silicon dioxide-based substrate includes a 1×1 cm 2 Silicon dioxide coated sensors, and glass microscope coverslips. RIfs-TIRFs sensors were cleaned in fresh piranha solution (one part 30% H2O2 and two parts concentrated H2SO4 - caution, highly corrosive). Glass microscope coverslips were cleaned in a plasma cleaner (Femto Plasma Systems, Diener Electronic GmbH / Germany) under vacuum obtained from ambient air. To coat the substrate with a graphene monolayer, the graphene monolayer was mixed with a protective polymer film (Easy Transfer Graphenea, Spain) cut into 5×5mm 2Small pieces of graphene were prepared. These small pieces were slowly immersed in MiliQ water to float on the water surface. The polymer-protected graphene monolayer was fished out from below through a clean glass coverslip or a silica RIfs-TIRFs sensor. This brought the graphene into face-to-face contact with the substrate. The obtained substrate was dried at room temperature for 30 minutes and then heated in a 150°C oven for 2 hours. The hot substrate was then removed from the oven and immediately stored under vacuum for 24 hours to cool. The substrate was then soaked in acetone for 1 hour and subsequently soaked in isopropanol for another 1 hour to remove the protective polymer film on the graphene. The graphene monolayer-coated substrate was blown dry with N2 for later use.

[0113] Example 2 Preparation of liposomes for non-covalent functionalization of graphene

[0114] To prepare DOPC liposomes, 2.5 μmol DOPC was dissolved in chloroform and mixed in a 50 mL round-bottom flask. To prepare liposomes containing DOPC: DOPS (95: 5 molar ratio), 2.4 μmol DOPC and 0.12 μmol DOPS were dissolved in chloroform and mixed in a 50 ml round-bottom flask. Similarly, a lipid mixture containing 2.4 μmol DOPC and 0.125 μmol tris-nitrilotriacetic acid-dioctadecylamine (trisNTA-DODA) was prepared in the same manner as the liposomes containing DOPC: trisNTA-DODA (95: 5 molar ratio). Chloroform in all the above lipid solutions was evaporated by a rotary evaporator, respectively. The dried lipids were dispersed in 10 mL HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.5) by vortexing for 30 minutes. The lipid solution was then probe-ultrasonicated 3 times in an ice-water bath for 5 minutes. After sonication, the solution was centrifuged at 20,000 rpm for 15 minutes. The supernatant was a liposome solution containing 250 μM lipid or lipid mixture.

[0115] Example 3 Calibration of distance-dependent graphene-induced energy transfer (GIET) by intensity measurement

[0116] The distance dependence of GIET was calibrated on a silica substrate coated with a graphene monolayer non-covalently modified by a lipid monolayer. Four single-stranded DNAs (ssDNAs) with 20-mer, 25-mer, 35-mer, and 50-mer nucleotides were designed as scaffolds for the nanoruler ( Figure 1A). These ssDNAs share a common 20-mer sequence at the 5' end as "anchor" chains and a cholesterol modification at the 3' end. To ensure vertical deposition of the oligonucleotides onto the lipid layer, 5% negatively charged DOPS was added to the matrix lipid DOPC, i.e., DOPC:DOPS (95:5 molar ratio). The "probe" chain has a common 20-mer ssDNA sequence complementary to the anchor chain. The probe chain is conjugated to 6-carboxyfluorescein (FAM) at the 3' end or 5' end, respectively, for fluorescent readout. The hybridization of the probe chain and the anchor chain is represented as "anchor chain-3'F or 5'F". For the 35-mer and 50-mer anchor chains, additional complementary 15-mer and 30-mer ssDNAs, respectively, are used as blockers to obtain full-length double-stranded DNA nanorulers. All DNA sequences are listed in Table 1.

[0117] Table 1 DNA strands used for calibration*

[0118]

[0119] Surface sensitive detection was performed using a homemade flow-through system with simultaneous reflection interference spectroscopy and total internal reflection fluorescence spectroscopy (RIfs-TIRFs) detection (see Gavutis et al., 2006, Nature Protocols, Vol. 1, p. 2091). In order to prepare a solid-supported lipid layer, liposomes containing 250 μM DOPC / DOPS (95:5 molar ratio) prepared in Example 2 were injected into a flow chamber mounted on a solid substrate. Alternatively, a lipid monolayer was formed on graphene using solution-assisted lipid deposition. In this method, liposomes containing 250 μM DOPC / DOPS (95:5 molar ratio) of HBS were dissolved in a mixed solution of HBS:EtOH (90:10 v / v). The mixture was injected into the flow chamber of the RIfs-TIRFs device. After forming a lipid layer on a solid support, cholesterol-modified ssDNA is injected to fix the anchor chain on the surface (in the anchor chain customized by IDT DNA, cholesterol is connected to ssDNA through a triethylene glycol TEG linker). FAM-labeled ssDNA is then injected as a probe chain to hybridize with the anchor chain. All DNA concentrations are 1 μM. The electrophoresis buffer used for DNA hybridization is HBS buffer containing Mg ions (HBS-Mg, 20mM HEPES, 150mM NaCl and 5mM MgCl2, pH 7.5). The RIfs-TIRFs signals of forming a lipid monolayer on graphene, fixing the ssDNA anchor chain and hybridizing with the probe chain on the lipid layer are monitored in real time. The fluorescence intensity (I GIET) were compared with the fluorescence intensity of the probe strand on silica (I0) in terms of the mass signal of the immobilized DNA strand. By assuming a tilt angle α between DNA and graphene, we calculated the vertical distance d. In summary, the seven measured I GIET / I0 ratio is plotted against d ( Figure 1 ). The obtained I GIET The dependence of / I0 on d matches the theoretical GIET curve, where the global fit has a tilt angle of 43 ± 1°. According to the verified intensity-based GIET curve, I GIET The / I0 ratio is 140 times that at 1 nm, 9.2 times that at 5 nm, 2.2 times that at 10 nm, and 1.1 times that at 20 nm. Using the intensity ratio, the detection sensitivity at 1 nm is 15 times higher than at 5 nm, 64 times higher than at 10 nm, and 127 times higher than at 20 nm.

[0120] Example 4 Calibration of distance-dependent GIET by lifetime measurement

[0121] Alternatively, the formation of lipid monolayer on graphene, the fixation of ssDNA anchor chain and the hybridization with the probe chain on the lipid layer are all carried out on graphene-coated glass microscope coverslips in vitro. The coverslips are mounted in a microscope chamber with a volume of 1 mL buffer. 800 μL of DOPC / DOPS (95:5 molar ratio) liposome solution prepared in Example 2 is added to the coverslip and incubated at room temperature for 30 minutes. The coverslips are washed with excess HBS to remove free liposomes in the solution. The coverslips are then incubated with 1 μM different ssDNA anchor chains for 15 minutes, and then washed 10 times with HBS-Mg buffer. 100 nM probe chain is added to the solution, and incubated for 15 minutes, and then washed 10 times with HBS. Using a confocal laser scanning microscope (Olympus FluoView 1000) equipped with a PicoQuant system (PicoHarp 300), the fluorescence quenching of graphene is quantified by time-correlated single photon counting (TCSPC). All TCSPC traces are fitted with a single exponential decay function. The lifetime ratio of graphene to glass (τ GIET / τ0) were grouped according to the 3' or 5' label of the probe strand. In the same manner as described in Example 3, the τ obtained from the seven DNA nanorulers GIET / τ0 plotted against the vertical distance d ( Figure 1 B). Both intensity and lifetime measurements show a sensitive GIET region between 1nm and 30nm. Significant differences in the nanometer scale between 35-5'F and 35-3'F were detected. The results confirm that GIET is highly sensitive to distance changes of 1.2nm.

[0122] Example 5 Determination of protein axial size using intensity-based GIET

[0123] Site-specific capture of His-tagged proteins on a graphene monolayer-coated silica sensor in a homemade RIfs-TIRFs setup. Liposomes containing 250 μM DOPC / trisNTA-DODA (95:5 molar ratio) were injected into a flow chamber mounted on a solid substrate. Alternatively, a lipid monolayer was formed on graphene using solution-assisted lipid deposition. In this method, ethanol was added to DOPC / trisNTA-DODA in HBS to obtain a final mixture of HBS:EtOH (90:10 volume ratio). The formation of a DOPC / tris-NTA DODA (95:5 molar ratio) lipid bilayer on a silica sensor showed 5.0 ng / mm 2 Surprisingly, the mass signal of lipid deposition on graphene is 2.5 ng / mm 2 The accurate half-mass signal indicates the formation of a densely packed trisNTA-DODA / DOPC lipid monolayer on graphene ( Figure 2 A) By loading Ni 2+ After the trisNTA-DODA / DOPC lipid monolayer on graphene was treated with ions, 1 μM hexahistidine-tagged anti-GFP nanobody (H6-NB) was injected, followed by 100 nM monomeric enhanced green fluorescent protein (GFP) ( Figure 2 B). Binding constants of the interaction between mEGFP and NB, and quantitative removal of the H6-NB::GFP complex by imidazole confirms the high affinity capture of fully functional His-tagged proteins on graphene. The fluorescence signal (I GIET ) was compared with the fluorescence signal on the silica substrate (I0), and an I of 16.4% was obtained by normalizing to the amount of immobilized protein. GIET / I0 ratio. Direct immobilization of H6-tagged GFP on graphene makes I GIET Using the calibrated GIET vs. distance curve, the I / I ratio of immobilized H6-tagged GFP was 7.6%. GIET The I / I0 ratio corresponds to 3.8 nm of the GFP fluorescent chromophore above the graphene. GIET The / I0 ratio is 16.4%, indicating that the GFP fluorescent chromophore in the composite is 5.5nm higher than that in graphene ( Figure 3 ).

[0124] Example 6 Quantification of DNA Axial Conformation Changes Using Lifetime-Based GIET

[0125] The graphene monolayer-coated coverslip was mounted in a microscope chamber with a 1 mL buffer volume. 800 μL of the DOPC / DOPS (95:5 molar ratio) liposome solution prepared in Example 2 was added to the coverslip and incubated at room temperature for 30 minutes. The coverslip was rinsed with excess HBS to remove free liposomes from the surface. Then 1 μM 35-mer ssDNA anchor chain was anchored to the lipid monolayer-coated graphene (DNA sequences are listed in Table 1). The lifetime τ was detected by TCSPC using a confocal laser scanning microscope by hybridization with a 100 nM 20-mer 3'FAM probe chain in solution. GIET Compared with the τ0 of 3.0ns on glass, the obtained τ GIET The / τ0 ratio is 8%, indicating a distance to graphene of 4.4 nm. This suggests that the hybridized probe-anchor DNA strand is located on the lipid monolayer due to the flexible, unpaired 15-mer gap. After adding 200 nM 15-mer ssDNA blocker strand to the solution, a lifetime of 1.5 ns ( Figure 4 B). According to the calibration curve, 49 ± 3% of τ GIET The ratio of / τ0 corresponds to a distance of 10.9 ± 0.2 above the graphene. The results indicate that the 35-mer ssDNA anchor chain hybridized to the probe adheres to the lipid monolayer in the static state. The binding of the 15-mer blocker renders the flexible gap rigid by additional hybridization with the dsDNA and stretching it to its full length ( Figure 4 ). This result confirms that GIET can measure molecular distance changes greater than 10 nm.

[0126] Example 7 DNA hybridization assay by intensity-based GIET

[0127] Surface sensitive detection was performed using a homemade flow-through system with simultaneous reflection interference spectroscopy and total internal reflection fluorescence spectroscopy (RIfs-TIRFs) detection (see Gavutis et al., 2006, Nature Protocols, Vol. 1, p. 2091). To prepare a solid-supported lipid layer, liposomes containing 250 μM DOPC / DOPS (95:5 molar ratio) prepared in Example 2 were injected into a flow chamber mounted on a solid substrate. Alternatively, a lipid monolayer was formed on graphene using solution-assisted lipid deposition. After the lipid layer was formed on the solid support, 1 μM cholesterol-modified ssDNA was injected to fix the anchor chain on the surface: GATGAATGGTGGGTGAGAGGTGAGG-cholesterol (25-mer anchor) shown in SEQ ID NO: 2. Subsequently, 1 μM FAM-labeled ssDNA (CCTCTCACCCACCATTCATC-FAM shown in SEQ ID NO: 5) was injected as a probe chain for hybridization with the anchor chain. The electrophoresis buffer used for DNA hybridization was HBS buffer (HBS-Mg, 20 mM HEPES, 150 mM NaCl and 5 mM MgCl2, pH 7.5) containing Mg ions. The RIfs-TIRFs signals of forming a lipid monolayer on graphene, fixing the ssDNA anchor chain and hybridizing with the probe chain on the lipid layer were monitored in real time. The fluorescence intensity (I GIET ) was compared with the fluorescence intensity of the probe strand on silica (I0) in terms of the mass signal of the immobilized DNA strand. The I GIET The ratio of / I0 reports a significant quenching of the probe ssDNA fluorescence intensity. This result confirms that the fluorescently labeled probe DNA strand is significantly quenched when hybridized with the DNA strand immobilized on the graphene-supported lipid monolayer.

[0128] Example 8 DNA hybridization assay with unlabeled DNA strands by intensity-based GIET

[0129] The same lipid layer formation process as in Example 7 was performed on the solid support. Then 1 μM cholesterol-modified ssDNA was injected for immobilization on the surface: GATGAATGGTGGGTGAGAGGTGAGGAGTAAGAGGATGTGTTAGAGGGATG-cholesterol (50-mer anchor) shown in SEQ ID NO:4. Subsequently, 1 μM probe strand FAM-labeled ssDNA (CCTCTCACCCACCATTCATC-FAM shown in SEQ ID NO:5 or FAM-CCTCTCACCCACCATTCATC shown in SEQ ID NO:6) was injected onto the solid support together with 1 μM unlabeled ssDNA strand (CATCCCTCTAACACATCCTCTTACTCCTCA shown in SEQ ID NO:8) to hybridize with the anchor strand. The electrophoresis buffer used for DNA hybridization was HBS buffer containing Mg ions (HBS-Mg, 20 mM HEPES, 150 mM NaCl and 5 mM MgCl2, pH 7.5). The RIfs-TIRFs signals of forming lipid monolayer on graphene, fixing ssDNA anchor chain and hybridizing with probe chain on lipid layer were monitored in real time. The fluorescence intensity (I GIET ) was corrected for the mass signal of the immobilized DNA strand with respect to the fluorescence intensity of the probe strand on silica (I0). The obtained I0 values ​​of 63.8 ± 1.9% and 41.9 ± 0.3% were GIET The ratio of I / I reported significant quenching of the fluorescence intensity of the two probe ssDNAs, respectively. The results confirmed that DNA hybridization on graphene-supported lipid monolayers is sensitive for the detection of fluorescently labeled DNA strands in combination with unlabeled DNA strands.

[0130] Example 9 DNA hybridization assay by lifespan-based GIET

[0131] The graphene monolayer-coated coverslip was mounted in a microscope chamber with a 1 mL buffer volume. 800 μL of the DOPC / DOPS (95:5 molar ratio) liposome solution prepared in Example 2 was added to the coverslip and incubated at room temperature for 30 minutes. The coverslip was rinsed with excess HBS to remove free liposomes from the surface. Then 1 μM GATGAATGGTGGGTGAGAGGTGAGGAGTAAGAGGA-cholesterol (35-mer ssDNA anchor chain) shown in SEQ ID NO:3 was anchored on the graphene coated with the lipid monolayer. The lifetime τ was detected by TCSPC using a confocal laser scanning microscope by hybridization with 100 nM CCTCTCACCCACCATTCATC-FAM (20-mer 3'FAM probe chain) shown in SEQ ID NO:5 in the solution.GIET After adding 200nM TCCTCTTACTCCTCA (15-mer ssDNA blocker chain) shown in SEQ ID NO:7 to the solution, τ GIET Lifetime is 1.5ns( Figure 4 B). The fluorescence lifetime obtained by two-step DNA hybridization is increased by a total of about 6 times. The results show that lifetime-based GIET can detect the hybridization of fluorescently labeled DNA chains on graphene-supported lipid monolayers in the presence of unlabeled DNA chains in solution.

[0132] Example 10 Synthesis of TrisNTA-PEG-DBCO

[0133] 11mg trisNTA-OEG7-disulfide (molecular weight 2978Da, homemade) was dissolved in 200μL HBS buffer. 2.2mg tris(2-carboxyethyl)phosphine hydrochloride (TCEP, molecular weight 286.6Da, Sigma Aldrich, C4706) in 100μL HBS was added to the trisNTA-OEG7-disulfide solution. The mixture was reacted at pH 7.5 for 15 minutes to obtain the reduced thiol compound trisnTA-OEG7-SH. The mixture was added to a 10mL glass round-bottom flask containing 300μL N,N-dimethylformamide (DMF) solution of 5mg dibenzocyclooctyne-PEG4-maleimide (DBCO-PEG4-Mal, molecular weight 674.7Da, Sigma Aldrich, 760676). The reaction mixture was stirred with a magnetic bar for 1 hour. The crude product was diluted with 10 mL of MiliQ water containing 0.2% (v / v) trifluoroacetic acid (TFA). The crude product was further purified by C18 RP-HPLC with a gradient of 0%-100% 0.2% TFA / acetonitrile in water. The purified compound was lyophilized to a white powder. Yield: 7.6 mg. MS (MALDI-TOF): 2187 [M+Na] + The obtained compound was named trisNTA-PEG-DBCO( Figure 5 ) and stored in 1 mg aliquots in glass vials at -20 °C.

[0134] Example 11 Synthesis of TrisNTA-PEG-pyrene

[0135] 5mg trisNTA-OEG7-disulfide (molecular weight 2978Da, homemade) was dissolved in 200μL HBS buffer. 1.0mg tris(2-carboxyethyl)phosphine hydrochloride (TCEP, molecular weight 286.6Da, Sigma Aldrich, C4706) in 100μL HBS was added to the trisNTA-OEG7-disulfide solution. The mixture was reacted at pH 7.5 for 15 minutes to obtain the reduced thiol compound trisnTA-OEG7-SH. The mixture was added to a 10mL glass round-bottom flask containing 300μL N,N-dimethylformamide (DMF) solution of 5mg pyrene-PEG2000-maleimide (pyrene-PEG2k-Mal, average molecular weight 2000Da, Creative PEGworks, PBL-9062). The reaction mixture was stirred with a magnetic bar for 1 hour. The crude product was diluted with 10 mL of MiliQ water containing 0.2% (v / v) trifluoroacetic acid (TFA) and purified by C18 RP-HPLC with a gradient of 0%-100% 0.2% TFA / acetonitrile in water. The purified compound was lyophilized. Yield: 5.8 mg white powder. MS (MALDI-TOF): 3512 [M+Na]+, multiple ±44 m / z peaks. The resulting compound was named trisNTA-PEG-pyrene ( Figure 5 ) and stored in 1 mg aliquots in glass vials at -20 °C.

[0136] Example 12 Graphene functionalization via π-π interactions with trisNTA-PEG-pyrene

[0137] 1 mg trisNTA-PEG-pyrene and 1 mg mPEG-pyrene (pyrene-PEG2k-OMe, average molecular weight 2000 Da, Creative PEGworks, PCN-102) were dissolved in water:ethanol (90:10 v / v). 50 μM trisNTA-PEG-pyrene / mPEG-pyrene (50:50 molar ratio) in water:ethanol (90:10 v / v) was injected into the flow chamber of the homemade RIfs-TIRFs device. The formation of trisNTA-PEG-pyrene / mPEG-pyrene layer on graphene was performed by 2.0 ng / mm 2 Quality signal characterization ( Figure 6 , stage I). The stable fixation of TrisNTA-PEG-pyrene / mPEG-pyrene monolayer confirmed the strong π-π interaction of pyrene on graphene. 2+ After the trisNTA-PEG-pyrene / mPEG-pyrene layer on the graphene was loaded, 1 μM hexahistidine-tagged monomeric enhanced green fluorescent protein (H6-GFP) ( Figure 6, Stages III and IV). The stable immobilization of H6-GFP and the quantitative removal of the H6-NB::GFP complex by imidazole validated the specific capture of His-tagged proteins on trisNTA-PEG-pyrene / mPEG-pyrene-modified graphene.

[0138] Example 13 Synthesis of BSA-HaloTag ligand conjugate

[0139] 75mg bovine serum albumin (BSA fraction V, Carl-Roth) was dissolved in 4mL HBS. 96mg N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC, Sigma Aldrich 03449) was dissolved in 1mL HBS. 3.9mg chlorohexane-OEG2-amine (HaloTag ligand, HTL, self-synthesized) was dissolved in 200μL ethanol. The three solutions were mixed in a 10mL round-bottom flask and magnetically stirred at 4°C for 4 hours. Using a membrane with a cutoff size of 14kDa, the reaction mixture was dialyzed in HBS buffer at 4°C for 48 hours. UV-vis absorption at 280nm indicated that the obtained solution contained 1.5mM BSA-HTL conjugate. The solution was frozen with liquid nitrogen and stored at -80°C.

[0140] Example 14 Synthesis of BSA-biotin conjugate

[0141] BSA-biotin was synthesized in the same manner as described in Example 13, but 4.1 mg of biotin (SigmaAldrich B4501) was used instead of 3.9 mg of HaloTag ligand. A final solution of 1.8 mM BSA-biotin was obtained and stored at -80°C.

[0142] Example 15 Graphene functionalization by amphiphilic molecules containing surface adhesion proteins

[0143] 20 μL of the BSA-HTL solution of Example 9 was applied to a graphene monolayer-coated silica sensor, which was then brought into face-to-face contact with another graphene-coated sensor. The sensor was then separated and washed three times with HBS. The sensor was incubated with 10 μM HaloTag-fused anti-GFP DARPin, which is a specific binder of GFP. The obtained sensor was washed three times with HBS buffer and stored in HBS buffer at 4°C before use. The GFP binding assay was performed in a homemade RIfs-TIRFs device. 500 nM monomeric enhanced green fluorescent protein (GFP) was injected into the flow chamber of the RIfs-TIRFs device. 1.5 ng / mm 2 The mass signal characterizes the immobilization of GFP on graphene ( Figure 7, gray bars). In contrast, the immobilization of GFP on the BSA-treated graphene monolayer coated on the sensor was negligible. The results confirmed that the amphiphilic BSA-HTL formed a stable functionalized layer on graphene. Therefore, the Halotag-fused anti-GFP DARPin was immobilized on graphene through the covalent coupling of HTL and HaloTag. GFP was then specifically captured from the solution to the amphiphilic molecule-functionalized graphene surface.

Claims

1. A method for determining the structure and / or dynamics of a target analyte, comprising immobilizing the target analyte to a graphene induced energy transfer (GIET) device and determining its distance-dependent GIET efficiency, The device comprises a support layer and a biofunctionalized graphene layer on the support layer, and the device is prepared by the following method, including: (a) transferring the graphene layer to the support layer to form a support layer having the graphene layer on top; (b) applying an amphiphilic coating to the graphene layer of step (a) to form a non-covalent surface coating on the graphene layer; and (c) obtaining a device having a support layer and a biofunctionalized graphene layer on the support layer; The amphiphilic coating comprises amphiphilic molecules having a hydrophobic group and a hydrophilic group, wherein the hydrophobic group and the hydrophilic group are connected via a connecting group, wherein the connecting group is a polymer, and wherein no cross-linking occurs between the molecules of the amphiphilic coating.

2. The method according to claim 1, wherein: (i) the hydrophilic group comprises an affinity capture moiety, and / or (ii) The hydrophobic group includes any one of the following: polycyclic aromatic hydrocarbon derivatives, cycloalkynes, surface adhesion proteins, and / or aliphatic amines.

3. The method according to claim 2, wherein: The hydrophobic group includes any one of the following: pyrene, cyclooctyne derivatives, bovine serum albumin, and / or fatty amine derivatives.

4. The method according to claim 3, wherein: The cyclooctyne derivative is a benzo-fused cyclooctyne derivative, and the aliphatic amine derivative is an octadecylamine derivative.

5. The method according to claim 2, wherein the affinity capture moiety is a target analyte capture moiety, and wherein the target analyte is a biomolecule comprising any one of a peptide or protein, an aptamer, a nucleic acid, a lipid and a carbohydrate.

6. The method according to claim 5, wherein the target analyte is a proteinogenic molecule or a nucleic acid molecule.

7. The method according to claim 5, wherein the target analyte is protein, DNA or RNA.

8. The method according to claim 2, wherein the affinity capture moiety is: (a) a protein capture ligand; or (b) a nucleic acid capture ligand; or (c) Chelating agents.

9. The method according to claim 8, wherein: The protein capture ligand is a halogenated alkyl derivative; the nucleic acid capture ligand is a complementary nucleic acid sequence, avidin or streptavidin or a binding protein; and the chelating agent is a carboxylic acid-based chelating agent.

10. The method according to claim 8, wherein the protein capture ligand is a chloroalkane derivative; and the chelating agent is a chelating agent based on diacetic acid or triacetic acid.

11. The method according to claim 8, wherein the chelating agent is a sequestering agent.

12. The method according to claim 1, wherein the linking group is poly(ethylene glycol) (PEG).

13. The method of claim 1, wherein the amphiphilic coating comprises amphiphilic molecules without affinity capture moieties.

14. The method according to claim 1, further comprising the steps of: The step of fixing the target analyte to the non-covalently modified surface of the graphene layer in step (c).

15. The method of claim 14, wherein the target analyte is immobilized to the non-covalent surface of the graphene layer by targeting or linking to a functional moiety of the one or more amphiphilic molecules.

16. The method of claim 15, wherein the functional moiety is targeted to or attached to a hydrophilic group of the one or more amphiphilic molecules.

17. The method according to any one of claims 1 to 16, wherein: The support layer includes any one of a silica-based material, a UV-curable plastic material, glass, silicon and / or a thermoplastic material.

18. The method of claim 17, wherein the support layer comprises a silicon dioxide based substrate.

19. The method of claim 17, wherein the support layer comprises silica glass.

20. The method according to any one of claims 1 to 16, measured by fluorescence quenching.

21. The method according to any one of claims 1 to 16, which is used to determine the axial size and / or axial conformational change of a target analyte.

22. The method of any one of claims 1 to 16, wherein: The lower limit of the detectable GIET region is 0.3 nm, 0.5 nm, 0.7 nm, 0.8 nm, 0.9 nm, 1 nm, 1.5 nm, 2 nm, 2.5 nm, 3 nm, 3.5 nm, 4 nm, 4.5 nm, or 5 nm.

23. The method of claim 22, wherein the detectable GIET region is 1-50 nm.

24. The method of claim 22, wherein the detectable GIET region is 3-40 nm.

25. The method of claim 24, wherein the detectable GIET region is 5-30 nm.

26. The method according to claim 1, wherein the amphiphilic molecule is: trisNTA-PEG-DBCO, trisNTA-PEG-pyrene.

Citation Information

Patent Citations

  • Graphene-based nanosensor for identifying target analytes

    US20170181669A1

  • Amphiphilic block copolymer and coating arrangement

    US20190169463A1

  • Graphene BIO-electronic sensing technology

    WO2018013586A1